Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral Alpha-Tocopherol in Tetralogy of Fallot Repair
NCT07194304Phase 1Completed
- Sponsor
- Dr. Cipto Mangunkusumo Hospital
- Start
- May 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in tetralogy of Fallot (TOF) comparing alpha-tocopherol with Placebo (2 arms). Primary endpoint: Change in Serum Troponin I Concentration. Started May 2022; status: completed.
02
Drugs
alpha-tocopherol
03
Conditions
tetralogy of Fallot (TOF)
Beyond the preview
Go deeper on NCT07194304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07194304.